Milestone Pharmaceuticals, Inc. (MIST)
1.04
-0.02
(-1.42%)
USD |
NASDAQ |
Aug 24, 16:00
1.05
+0.01
(+0.96%)
After-Hours: 20:00
Milestone Pharmaceuticals Shareholders Equity (Quarterly) : 18.22M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.22M |
| March 31, 2026 | 36.05M |
| December 31, 2025 | 41.77M |
| September 30, 2025 | 20.50M |
| June 30, 2025 | -17.74M |
| March 31, 2025 | -6.123M |
| December 31, 2024 | 13.15M |
| September 30, 2024 | 24.01M |
| June 30, 2024 | 31.98M |
| March 31, 2024 | 39.92M |
| December 31, 2023 | 16.77M |
| September 30, 2023 | 28.50M |
| June 30, 2023 | 40.41M |
| March 31, 2023 | 53.94M |
| December 31, 2022 | 66.35M |
| Date | Value |
|---|---|
| September 30, 2022 | 77.16M |
| June 30, 2022 | 86.66M |
| March 31, 2022 | 100.76M |
| December 31, 2021 | 112.60M |
| September 30, 2021 | 127.42M |
| June 30, 2021 | 139.59M |
| March 31, 2021 | 131.99M |
| December 31, 2020 | 143.12M |
| September 30, 2020 | 102.20M |
| June 30, 2020 | 88.02M |
| March 31, 2020 | 99.63M |
| December 31, 2019 | 114.92M |
| September 30, 2019 | 132.83M |
| June 30, 2019 | 145.31M |
| March 31, 2019 | 73.33M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 6.892M |
| NervGen Pharma Corp. | 12.18M |
| Clearmind Medicine, Inc. | 11.49M |
| Lexaria Bioscience Corp. | 4.738M |
| Target Group, Inc. (Canada) | -8.655M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 181.62M |
| Total Liabilities (Quarterly) | 163.41M |
| Debt to Equity Ratio | 7.785 |
| Current Ratio | 8.129 |
| Net Debt Paydown Yield | -10.34% |